Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-052259

Options or other derivatives

  • Director acquired 41,349 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hallock Kenneth Director 2024-12-24 Grant or award · Stock Options +41,349 82,698 D: show line 1 in the form
Loading xslF345X05/ownership.xml…